Literature DB >> 12575950

RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

Kevin Y Miyashiro1, Andrea Beckel-Mitchener, T Patrick Purk, Kevin G Becker, Tanya Barret, Lei Liu, Salvatore Carbonetto, Ivan Jeanne Weiler, William T Greenough, James Eberwine.   

Abstract

The Fragile X mental retardation-1 (Fmr1) gene encodes a multifunctional protein, FMRP, with intrinsic RNA binding activity. We have developed an approach, antibody-positioned RNA amplification (APRA), to identify the RNA cargoes associated with the in vivo configured FMRP messenger ribonucleoprotein (mRNP) complex. Using APRA as a primary screen, putative FMRP RNA cargoes were assayed for their ability to bind directly to FMRP using traditional methods of assessing RNA-protein interactions, including UV-crosslinking and filter binding assays. Approximately 60% of the APRA-defined mRNAs directly associate with FMRP. By examining a subset of these mRNAs and their encoded proteins in brain tissue from Fmr1 knockout mice, we have observed that some of these cargoes as well as the proteins they encode show discrete changes in abundance and/or differential subcellular distribution. These data are consistent with spatially selective regulation of multiple biological pathways by FMRP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12575950     DOI: 10.1016/s0896-6273(03)00034-5

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  199 in total

Review 1.  Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling.

Authors:  James Eberwine; Brian Belt; Janet Estee Kacharmina; Kevin Miyashiro
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

Review 2.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

3.  Fragile X syndrome and attention-deficit/hyperactivity disorder symptoms.

Authors:  Presenter Swapna Deshpande; Discussant Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12       Impact factor: 2.576

Review 4.  The regulation of AβPP expression by RNA-binding proteins.

Authors:  Cara J Westmark; James S Malter
Journal:  Ageing Res Rev       Date:  2012-04-05       Impact factor: 10.895

Review 5.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

Review 6.  Fragile X: leading the way for targeted treatments in autism.

Authors:  Lulu W Wang; Elizabeth Berry-Kravis; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 7.  Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Authors:  Lawrence K Fung; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2015-12-18       Impact factor: 13.382

8.  Fragile X mental retardation protein controls trailer hitch expression and cleavage furrow formation in Drosophila embryos.

Authors:  Kate Monzo; Ophelia Papoulas; Greg T Cantin; Yan Wang; John R Yates; John C Sisson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

Review 9.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

10.  Retinoic acid-gated sequence-specific translational control by RARalpha.

Authors:  Michael M Poon; Lu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.